NEW YORK, July 2 - Larry Hill has been appointed CEO of Deltagen in the wake of its Chapter 11 bankruptcy, and Daniel Ratto has been appointed chief financial officer, the company announced late last Friday.
Hill, a principal at the corporate restructuring and management firm Hickey & Hill, will head up the company during its reorganization.
Joseph Limber, a former CEO of Aclara who was appointed CEO of Deltagen in April, stepped down in mid-June, along with John Varian, the company's interim chief financial officer. The two left when it became apparent that the company would not be able to close its Series A financing.
Annuk was previously an associate preofessor and head of surgical anatomy at Tartu University in Estonia, where he received his MD degree. He has also done research in renal diseases and transplants at University Hospital in Uppsala, Sweden.
Joseph Smith has been appointed vice president and general counsel, and Russel Enns has been named vice president of regulatory and clinical affairs at Cepheid, the company said June 30.
Smith was most recently vice president, business development, at Applied Biosystems. Prior to that, he was ABI's vice president of Intellectual Property, where he formed the legal department in 1989. He also was previously a partner at the IP law firms of Wiseman, Jones, and Smith, and Boone, Fox, and Jones, and was part of Hewlett-Packard's technical legal department.
Enns comes to Cepheid from work as a regulatory consultant, and before that, a position as vice president regulatory affairs, quality system, clinical affairs and medical reimbursement at Abbott subsidiary Vysis. He has also served as vice president of technical affairs at MicroProbe, and director of product development, clinical programs and technical affairs at Gen-Probe.
Ian Howes was appointed CFO and senior vice president of finance and administration at Serenex, and Anil Goyal was named vice president of business development.
Howes comes to the Durham, NC drug discovery company from Paradigm Genetics, where he was CFO. He has also served as CFO of Analytika, American Care Communities, and EnSys.
Goyal joins Serenex from Millennium Pharmaceuticals, where he was senior manager of corporate development. He also served as manager of business development at Genome Therapeutics.